Table 1.
Patients’ baseline characteristics
| Characteristics | Mean ± SD or n (%) |
|---|---|
| Age (years) | 31.5±6.6 |
| Male/female | 93 (72.1)/36 (27.9) |
| Genotype B/C | 87 (67.4)/42 (32.6) |
| Stage of fibrosis* | |
| F0 | 42 (32.6) |
| F1 | 60 (46.5) |
| F2 | 14 (10.9) |
| F3 | 7 (5.4) |
| F4 | 6 (4.7) |
| Log10 HBV DNA (copies/mL) | 7.5±1.2 |
| ALT (IU/L) | 32.3±17.7 |
| LSM (kPa) | 6.7±3.0 |
| Log10 HBsAg (IU/mL) | 4.3±0.9 |
Notes:
*
Stage of fibrosis was evaluated according to the METAVIR scoring system.
Abbreviations: ALT, alanine aminotransferase; DNA, deoxyribonucleic acid; F0, no fibrosis; F1, portal fibrosis without septa; F2, portal fibrosis with few septa; F3, numerous septa without cirrhosis; F4, cirrhosis; HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; LSM, liver stiffness measurement; SD, standard deviation.